Mounjaro

Mounjaro, with its active ingredient tirzepatide, offers a beacon of hope for adults grappling with type 2 diabetes or obesity. However, like any medication, it comes with potential side effects.

To get a prescription for Mounjaro, individuals living with obesity (BMI>30). For those living with type-2 diabetes in the UK, the National Institute for Health and Care Excellence (NICE)

Mounjaro, a medication for managing blood sugar levels in adults with type 2 diabetes, is administered as a weekly injection of a liquid solution under the skin. Alongside a balanced diet and regular exercise

Tirzepatide, known by its brand name Mounjaro is manufactured by Eli Lilly and represents a new class of medication designed for weight management and the treatment of type 2 diabetes.

When it comes to managing type 2 diabetes or chronic weight management there are several medications available. The two most common options today are the breakthrough drugs Ozempic and Mounjaro.

Mounjaro Mounjaro is a groundbreaking FDA-approved medication that represents a new frontier in the treatment of type 2 diabetes and the treatment of obesity. Its active ingredient, Tirzepatide, is a dual GIP and GLP-1 receptor agonist, a novel approach that not only enhances the body’s ability to regulate blood sugar levels but also supports weight … Read more